| Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013 | 645 | 2013 |
| GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013 | 415 | 2013 |
| Identification of six new susceptibility loci for invasive epithelial ovarian cancer KB Kuchenbaecker, SJ Ramus, J Tyrer, A Lee, HC Shen, J Beesley, ... Nature genetics 47 (2), 164-171, 2015 | 307 | 2015 |
| Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer H Shen, BL Fridley, H Song, K Lawrenson, JM Cunningham, SJ Ramus, ... Nature communications 4 (1), 1628, 2013 | 178 | 2013 |
| HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer AE Teschendorff, SH Lee, A Jones, H Fiegl, M Kalwa, W Wagner, ... Genome medicine 7, 1-12, 2015 | 164 | 2015 |
| Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium CM Nagle, SC Dixon, A Jensen, SK Kjaer, F Modugno, A DeFazio, ... British journal of cancer 113 (5), 817-826, 2015 | 157 | 2015 |
| Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21. 31 J Permuth-Wey, K Lawrenson, HC Shen, A Velkova, JP Tyrer, Z Chen, ... Nature communications 4 (1), 1627, 2013 | 136 | 2013 |
| ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer EL Hedditch, B Gao, AJ Russell, Y Lu, C Emmanuel, J Beesley, ... JNCI: Journal of the National Cancer Institute 106 (7), dju149, 2014 | 134 | 2014 |
| Sarcopenia and ovarian cancer survival: a systematic review and meta‐analysis J Ubachs, J Ziemons, IJG Minis‐Rutten, RFPM Kruitwagen, J Kleijnen, ... Journal of cachexia, sarcopenia and muscle 10 (6), 1165-1174, 2019 | 132 | 2019 |
| Genome-wide significant risk associations for mucinous ovarian carcinoma Australian Ovarian Cancer Study Group, H Baker, EV Bandera, Y Bean, ... Nature genetics 47 (8), 888-897, 2015 | 116 | 2015 |
| Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods EMJ Meys, LS Jeelof, NMJ Achten, BFM Slangen, S Lambrechts, ... Ultrasound in Obstetrics & Gynecology 49 (6), 784-792, 2017 | 113 | 2017 |
| Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome I Kalogiannidis, S Lambrechts, F Amant, P Neven, T Van Gorp, I Vergote American journal of obstetrics and gynecology 196 (3), 248. e1-248. e8, 2007 | 108 | 2007 |
| BRCA1 gene promoter methylation status in high-grade serous ovarian cancer patients–a study of the tumour Bank ovarian cancer (TOC) and ovarian cancer diagnosis consortium (OVCAD) I Ruscito, D Dimitrova, I Vasconcelos, K Gellhaus, T Schwachula, F Bellati, ... European journal of cancer 50 (12), 2090-2098, 2014 | 99 | 2014 |
| Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study SC Dixon, CM Nagle, AP Thrift, PDP Pharoah, CL Pearce, W Zheng, ... International journal of epidemiology 45 (3), 884-895, 2016 | 89 | 2016 |
| Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer K Lawrenson, Q Li, S Kar, JH Seo, J Tyrer, TJ Spindler, J Lee, Y Chen, ... Nature communications 6 (1), 8234, 2015 | 85 | 2015 |
| The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment E Despierre, D Lambrechts, P Neven, F Amant, S Lambrechts, I Vergote Gynecologic oncology 117 (2), 358-365, 2010 | 83 | 2010 |
| Prognostic impact of tumor infiltrating CD8+ T cells in association with cell proliferation in ovarian cancer patients-a study of the OVCAD consortium A Bachmayr-Heyda, S Aust, G Heinze, S Polterauer, C Grimm, EI Braicu, ... BMC cancer 13, 1-8, 2013 | 75 | 2013 |
| Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients–a study of the OVCAD consortium D Pils, A Bachmayr-Heyda, K Auer, M Svoboda, V Auner, G Hager, ... European journal of cancer 50 (1), 99-110, 2014 | 66 | 2014 |
| Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy E Despierre, S Lambrechts, K Leunen, P Berteloot, P Neven, F Amant, ... Gynecologic oncology 130 (1), 192-199, 2013 | 66 | 2013 |
| Treatment reality in elderly patients with advanced ovarian cancer: a prospective analysis of the OVCAD consortium F Trillsch, L Woelber, C Eulenburg, I Braicu, S Lambrechts, R Chekerov, ... Journal of ovarian research 6, 1-9, 2013 | 65 | 2013 |
